Imperial Brands Expects Net Revenue Growth in Low Single Digits

Apr.14.2023
Imperial Brands Expects Net Revenue Growth in Low Single Digits
Tobacco and e-cigarette manufacturer Imperial Brands expects low net revenue growth and increased profit within three years.

On April 13th, tobacco and e-cigarette manufacturer Imperial Brands announced that it is steadily working towards meeting its full-year expectations and anticipates achieving low single-digit net revenue growth. Over the next three years, the company expects its operating profit growth to accelerate, reaching a median compound annual growth rate.


The announcement highlights its main core features in five key points.


The company maintained a strong market share and stable tobacco pricing in five major combustible tobacco markets. The launch of new products such as e-cigarettes, heated tobacco, and modern oral products also contributed to the growth of net income. Despite the impact of COVID-19, the group's adjusted operating profit in the first half of the year remained unchanged from the same period last year, reflecting the effects of COVID-19 on cigarette sales, increased investment in new products, and the impact of exiting the Russian market last year. The company is expected to achieve revenue and profit growth in line with expectations and guidance for the full year. They have completed £523 million of their £1 billion share buyback program for the fiscal year 2023, which represents approximately 2.7% of the issued share capital.


Combustible tobacco market.


Imperial Tobacco is predicting that their market share in the five major markets will remain steady or increase compared to the same period last year in the first half of this year. Although their market share in Germany and the UK is expected to decline, the market share in the US, Spain, and Australia is expected to remain stable or grow, offsetting the decline in those two countries. The company has maintained a strict pricing system in these five major markets.


New tobacco market.


Imperial Tobacco has made progress in the development and launch of new tobacco products. In the e-cigarette market, they have introduced the blu 2.0 product in the UK, Spain, France, Czech Republic, and Portugal.


Due to the strong growth in Europe, it is expected that revenue from new tobacco products will exceed that of the same period last year in the first half of the year. This is enough to offset the decline caused by the uncertainty from the US marketing ban.


Central and Eastern Europe have been integrated into the AAA region, creating the AAACE region.


Imperial Tobacco is transferring the management of its Central and Eastern Europe (CEE) cluster from Europe to the African, Asian, and Australian (AAA) region. The AAA region will now be referred to as AAACE.


The markets that have been affected by the transfer of regional management this time include Poland, the Czech Republic, Ukraine, Slovakia, Hungary, Azerbaijan, Armenia, Georgia, Moldova, Croatia, and Slovenia.


In the half-year restatement report ending on March 31, 2023, Imperial Tobacco reported a total revenue of £1.37 billion in the New Europe region and £965 million in the AAACE region.


The primary source of revenue for the new tobacco industry is Europe. The revenue generated by the new tobacco industry in the New Europe region is worth £74 million, while the Old Europe region generates £77 million worth of revenue. The new tobacco industry in Europe accounts for 5.4% of total revenue.


Note: The original amount of 1.569 billion pounds for Europe minus 199 million pounds for the Central and Eastern European (CEE) region equals the new amount of 1.37 billion pounds for the expanded European region.


The total amount of 965 million pounds was obtained by combining 766 million pounds from the AAA region and 199 million pounds from the CEE region in the AAACE region.


Imperial Brands PLC has published a report according to an announcement made by the company.


The mid-year performance report covering the period ending March 31, 2023, will be released to the public on May 16, 2023.


Reference:


Imperial Brands is expected to meet full-year guidance based on the pre-close trading update.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's Ministry of Gender Equality and Family said on September 14 that it plans to designate unmanned e-cigarette stores as businesses where minors are prohibited from entering or working. Operators would be required to verify customers' ages and display notices restricting access by minors. The proposal is open for public comment through October 6. The move follows an April expansion of South Korea's statutory tobacco definition that brought products made with natural or synthetic nicotine under the Tobacco Business Act. Nicotine-free liquids and products using nicotine analogues such as 6-methylnicotine, however, remain an emerging regulatory issue.
Sep.21
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24